Cargando…
Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma
SIMPLE SUMMARY: Many solid tumours, such as those of the breast, colon, and prostate, have well established molecular markers of malignancy. However, in certain cancers, such as squamous cell carcinoma (SCC), few clinically useful biomarkers exist. Recently, several candidates that might be used for...
Autores principales: | Chen, Kathryn, Yong, Joel, Zauner, Roland, Wally, Verena, Whitelock, John, Sajinovic, Mila, Kopecki, Zlatko, Liang, Kang, Scott, Kieran Francis, Mellick, Albert Sleiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688099/ https://www.ncbi.nlm.nih.gov/pubmed/36428658 http://dx.doi.org/10.3390/cancers14225564 |
Ejemplares similares
-
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
por: Wimmer, Monika, et al.
Publicado: (2020) -
Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
por: Siebert, Justin R., et al.
Publicado: (2014) -
Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans
por: Rauvala, Heikki, et al.
Publicado: (2017) -
Roles of Chondroitin Sulfate Proteoglycans as Regulators of Skeletal Development
por: Schwartz, Nancy B., et al.
Publicado: (2022) -
Induction of chondroitin sulfate proteoglycan synthesis and secretion in lymphocytes and monocytes
Publicado: (1983)